Change - Announcement of Cessation::Cessation of Chief Financial Officer

Issuer & Securities

Issuer/ Manager
V2Y CORPORATION LTD.
Securities
V2Y CORPORATION LTD. - SGXE31442804 - V2Y
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
21-Feb-2025 17:53:13
Status
New
Announcement Sub Title
Cessation of Chief Financial Officer
Announcement Reference
SG250221OTHRL6HS
Submitted By (Co./ Ind. Name)
Ang Wei Yang Felix
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
This announcement has been reviewed by the Company's Sponsor, Evolve Capital Advisory Private Limited (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document.

The contact person for the sponsor is Mr. Lay Shi Wei at 160 Robinson Road, #20-01/02 SBF Center, Singapore 068914, telephone (65) 6241 6626.

Additional Details

Name Of Person
Chia Wildy
Age
46
Is effective date of cessation known?
Yes
If yes, please provide the date
28/02/2025
Detailed Reason (s) for cessation
Mr Chia Wildy ("Mr Chia") had tendered his resignation due to health reasons.

After having interviewed Mr Chia and to the best of its knowledge, the Sponsor is satisfied that there are no other material reasons for the cessation of Mr Chia as Chief Financial Officer.

Mr Chia will continue to provide assistance as part of the transition until 31 March 2025 on a contract basis. The Company is in the midst of searching for a suitable candidate to be appointed as Financial Controller or Chief Financial Officer and will update shareholders accordingly.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
03/01/2025
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
3
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Financial Officer
Role and responsibilities
Executive.

Mr Chia will be responsible for overseeing the financial, accounting and corporate secretarial matters in the Group, including leading and supervising the monthly accounts closing, consolidation of Group accounts and yearly audits, supervising and ensuring the Group's compliance with taxation and financial reporting requirements, and providing overall supervisory control over the Group's finances, liabilities and cashflows.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
Mr Chia is a director and 50% shareholder of Vetdicate Pte. Ltd. ("Vetdicate"). Mr Ang Wei Yang Felix, the Chief Executive Officer and Executive Director of V2Y Corporation Ltd. (the "Company"), is also a director and 50% shareholder of Vetdicate. Both Mr Chia and Mr Ang Wei Yang Felix had been business associates. Mr Chia has confirmed that Vetdicate has no business dealings with the Company and/or its subsidiaries (the "Group") and is dormant.

Save as disclosed above, Mr Chia has no other relationship or business dealings with the Group, existing directors and executive officers, and/ or substantial shareholders of the Company or any of its principal subsidiaries.
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
Directorships
(1) ATKG Pte. Ltd.
(2) Varic Pte. Ltd.

Other Principal Commitments
Nil
Present
Directorships
(1) Intelligent Works Pte. Ltd.
(2) Vetdicate Pte. Ltd.

Other Principal Commitments
Nil